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Abstract
Staphylococcus aureus is a major human pathogen causing commu-
nity- and hospital-acquired infections. Capsule production of
S. aureus confers protection against host defence. There is a lack
of information concerning the association of capsular polysaccha-
ride (CP) expression and activity of the accessory gene regulator
(agr) in clinical S. aureus isolates. Production of CP and agr
expression were assessed in 195 S. aureus isolates from infected
patients at a German University Hospital. Northern blot analysis
revealed that S. aureus strains with a non-functional agr locus were
more likely to be CP-negative than strains with a functional agr
locus.
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Staphylococcus aureus is a major human pathogen that causes a
wide spectrum of community- and hospital-acquired diseases,
ranging from local infections such as skin and soft tissue
infections, e.g. impetigo, carbuncle, furuncle and cellulitis, to
more life-threatening infections such as sepsis, pneumonia and
endocarditis [1].
To cause such a variety of infections, S. aureus is equipped
with numerous virulence factors, many of which are differen-
tially regulated by RNAIII encoded by the agr operon [2].
Agr functions as a quorum sensing system by secreting an
auto-inducing peptide [3]. Sequence variations within the
peptide and its transmembrane receptor agrC distinguish four
agr-speciﬁcity groups [4]. The agr locus positively regulates
capsule expression, which confers resistance to phagocytosis
[5].
The majority of S. aureus clinical isolates (c.70%) produce
capsular polysaccharides (CP) with serotype 8 (CP8) being
most prevalent followed by serotype 5 (CP5) with some
geographical variations [6].
The results of experimental infection studies have revealed
that agr-mutants are signiﬁcantly attenuated in animals [7,8].
Moreover, two separate studies indicated that S. aureus strains
with a defect in agr function were associated with persistent
bacteraemia and poor clinical outcome [9,10]. The authors
speculated that this might be because of increased production
of cell surface proteins that facilitate bioﬁlm formation,
immune evasion and persistent infection.
There is a lack of information concerning the association of
CP expression and agr activity in clinical S. aureus isolates. We
hypothesized that lack of CP production by clinical isolates is
the result of a non-functional agr locus in these strains. During
a 12-month period we collected 195 S. aureus isolates
(Table 1) from infected or colonized patients treated at the
tertiary University Hospital of M€unster (1400 beds). In our
study out of 195 clinical strains, 17 strains were penicillin-
susceptible S. aureus (9%), 168 strains were methicillin-suscep-
tible S. aureus (86%) and ten strains were methicillin-resistant
S. aureus (5%). Production of CP was evaluated by colony
immunoblot (Fig. 1a) [11] and RNAIII transcription was
assessed by Northern blot analysis (Fig. 1b) [12]. Multiplex
PCR was performed to determine agr and capsule genotypes
[13]. Chi-squared test was used to analyse the statistical
signiﬁcance of the results.
All 195 isolates were genotypically and phenotypically
characterized for capsule types and expression. Multiplex
PCR (Fig. 1a) revealed that all were either cap5 (n = 78,
40%) or cap8 (n = 117, 60%). Forty-ﬁve isolates (23%)
expressed CP5, 80 (40%) expressed CP8 and 70 strains
(36%) were phenotypically non-typeable (NT) as indicated by
immunoblot analysis, suggesting that they expressed no
capsule (Fig. 1b).
As agr function is known to vary in clinical isolates, and was
shown in laboratory strains to regulate capsule expression
[11], its function among these clinical isolates was tested. In
Northern blot analysis we identiﬁed 49% of our clinical isolates
as having an inactive agr locus, as shown by the lack of an
RNAIII transcript (Table 1). This ﬁnding is in contrast to that
of Traber et al. [14], who reported that <23% of their clinical
isolates from a single hospital had a dysfunctional agr locus.
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TABLE 1. Analysis of agr expression and capsule phenotype in clinical Staphylococcus aureus strains from different sources
Source of isolate
agr activity (%) Capsule phenotype (%)
Positive (n = 100) Negative (n = 95) CP5 (n = 45) CP8 (n = 80) NT (n = 70)
Abscess (n = 23) 16 (70) 7 (30) 4 (17.4) 11 (47.8) 8 (34,8)
Arthritis (n = 6) 5 (82) 1 (18) 3 (50) 0 (0) 3 (50)
Bone (n = 15) 6 (40) 9 (60) 2 (13.3) 5 (33.3) 8 (53,3)
Catheter (n = 19) 11 (57.9) 8 (42.1) 3 (15.8) 11 (57.9) 5 (26,3)
CNS (n = 19) 14 (73.7) 5 (26.3) 4 (21.1) 7 (36.8) 8 (33,3)
Eye (n = 3) 3 (100) 0 (0) 0 (0) 2 (66.7) 1 (33,3)
Nasal colonization (n = 46) 20 (43.5) 26 (56.5) 5 (10.9) 25 (54.4) 16 (34,7)
Otitis (n = 9) 3 (33.3) 6 (66.7) 4 (44.4) 3 (33.3) 2 (22,2)
Pneumonia (n = 11) 6 (46.2) 7 (53.8) 1 (9.1) 8 (72.7) 2 (18,2)
Prosthesis (n = 11) 6 (54.5) 5 (45.5) 2 (18.2) 5 (45.5) 4 (36,4)
Sepsis (n = 5) 3 (60) 2 (40) 2 (40) 2 (40) 1 (20)
Skin (n = 11) 3 (27.3) 8 (72.7) 6 (54.5) 3 (27.3) 2 (18,2)
Soft tissue (n = 25) 10 (40) 15 (60) 8 (32) 8 (32) 9 (36)
Urinary tract (n = 2) 2 (100) 0 (0) 0 (0) 0 (0) 2 (100)
Wound (n = 25) 11 (44) 14 (56) 4 (16) 9 (36) 12 (48)
CNS, central nervous system, CP, capsular polysaccharide; NT, non-typeable.
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FIG. 1. (a) After overnight culture of the clinical isolates, total cellular RNA was isolated using the FastPrep system (Fast prep FP120 Instrument;
Qbiogene, Heidelberg, Germany). Ten micrograms of RNA was electrophoresed through a 1.5% 0.66 M formaldehyde gel in morpholinepropane
sulfonic acid (MOPS) running buffer. Every gel was controlled for equal loading of RNA. RNA was transferred using standard procedures. The
membranes were hybridized with the digoxigenin-labelled probe and detected by chemiluminescence (Roche, Mannheim, Germany). As a positive
control RN6390 [21] and as a negative control RN6311 [22] were used. The results were deﬁned as positive in the case of visible bands and negative
if no band could be detected. (b) Capsule typing of all 195 isolates was performed according to ref. [11] by colony immunoblot method with capsular
polysaccharide 5 (CP5) or CP8-speciﬁc antibodies. The reactivities of the clinical isolates were evaluated in comparison to those of control
Staphylococcus aureus strains included on each ﬁlter membrane (JL278 CP5; PS80 CP8; JL801 non-typeable). Isolates with no reaction to CP5 and CP8
antibodies were deﬁned as non-typeable.
TABLE 2. Loss of agr activity is associated with a non-encapsulated phenotype in clinical Staphylococcus aureus strains. Agr activity
was assessed by Northern blot analysis, capsule expression by colony immunoblot and agr groups by agr multiplex PCR in 195
clinical S. aureus strains
agr activity
Capsule phenotype (%) Capsule genotype (%) agr groups (%)
CP5 (n = 45) CP8 (n = 80) NT (n = 70) cap5 (n = 78) cap8 (n = 117) I (n = 90) II (n = 59) III (n = 32) IV (n = 14)
Positive
(n = 100)
31 (68.9) 42 (52.5) 27 (38.6) 45 (45) 55 (55) 54 (54) 28 (28) 16 (16) 2 (2)
Negative
(n = 95)
14 (31.1) 38 (47.5) 43 (61.4) 33 (34.7) 62 (65.3) 36 (37.9) 31 (32.6) 16 (16.8) 12 (12.6)
p 0.0079 p 0.188 p 0.013
CP, capsular polysaccharide; NT, non-typeable.
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Phenotypically acapsular strains are signiﬁcantly associated
with a defect in agr function compared with encapsulated
strains (Table 2; p 0.0070), supporting the important role of
agr for CP expression by S. aureus.
In a previous study, which characterized the capsule locus
from NT S. aureus in a smaller number of clinical strains, three
out of 16 NT S. aureus strains were shown to have a
non-functional agr locus based on a RNA dot blot analysis [15].
To our knowledge this is the ﬁrst report to demonstrate
that CP non-typeable clinical strains from an array of
important S. aureus infections are signiﬁcantly associated with
an inactive agr-locus.
The correlation of agr function and the disease type of
abscesses, central nervous system infections and catheter
infection showed that these infections were signiﬁcantly
associated with a functional agr locus (p 0.0146). However,
all other disease types were not signiﬁcantly associated with a
defect in agr function (Table 1).
It is not clearly understood which factors lead to the loss of
agr activity in clinical S. aureus strains. Smyth et al. recently
reported that paired strains cultured from blood and nares
were mostly identical in their agr function, suggesting that
attenuation of agr activity does not happen during the
transition from nasal colonization to bloodstream infection
[16].
Obviously, other factors in addition to agr-regulated
virulence factors enable agr-negative S. aureus strains to cause
infection in humans. RNAIII down-regulates staphylococcal
surface adhesin expression. Furthermore, mutations in agr are
responsible for diminished CP5 production [5]. Because CP
can no longer mask bacterial surface adhesins, agr mutants may
preferentially colonize and persist in the host [17].
Encapsulated S. aureus isolates were more virulent than
capsule mutants in experimental animal models of bacteraemia,
septic arthritis and abscess formation [18]. However, depend-
ing on the model, capsule mutants were more virulent in a rat
model of catheter-induced staphylococcal endocarditis [19]
and persisted for longer in the infected mammary gland of
lactating mice compared with the encapsulated parental
S. aureus strain [20]. In line with increased persistence, capsule
mutants did adhere better to platelets and were internalized to
a higher degree by MAC-T bovine epithelial cells compared
with CP-positive strains [20]. These ﬁndings suggest that
alterations in CP expression correlate with a chronic state of
infection.
It is known that certain types of infections are associated
with speciﬁc agr-groups [4]. Analysis of agr groups and RNAIII
activity revealed that agr group I isolates were associated with
a functional agr operon (Table 2; p 0.013).
In conclusion, we have identiﬁed 49% of S. aureus with agr
dysfunction among 195 clinical isolates. Failure to detect
RNAIII by Northern blot was associated with a lack of CP
production. Our ﬁndings indicate that S. aureus isolates with
agr inactivity belong to the natural S. aureus population, and
that such strains may have been selected during the infectious
process, thereby contributing to persistent infection.
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